Although part of the same drug class as Wegovy , Zepbound differs slightly from other GLP-1 medications in that it targets two hormone receptors: glucagon-like peptide-1 (GLP-1) and glucagon-like peptide-1 (GIP)
Questions about how Michigan law applies to your situation
i tng khc Ngi gi: Nn iu chnh gim liu thch hp v gim st l cn thit trong sut thi gian s dng thuc
Semaglutide engages one receptor (GLP-1), tirzepatide engages two (GIP and GLP-1), and retatrutide engages three (GLP-1, GIP, and glucagon)
Over time, this can show up as: Fatigue or sluggish energy Hair thinning or dull skin Low mood or brain fog Muscle weakness or cramps The truth is simple: while Semaglutide helps with weight loss, your body still needs the fuel to function at its best
It needs stronger oversight of the medical evaluation process